Jump to main content.

Novartis Pharmaceuticals Corporation

Other (Former) Names of Site: Sandoz

EPA Identification Number: NJD002147023
Facility Location: 59 Route 10, East Hanover, New Jersey 07936   
Link to the site map
Facility Contact: Michael Draikiwicz, (862) 778-7682, michael.draikiwicz@novartis.com
EPA Contact: Sameh Abdellatif, (212) 637-4103, abdellatif.sameh@epa.gov
New Jersey Department of Environmental Protection (NJDEP) Case Manager: Erica Bergman, (609) 292-7406, erica.bergman@dep.state.nj.us
Last Updated: May 2011
Environmental Indicator Status

Human Exposures Under Control [PDF 33.51 KB, 10 pp] has been verified.
Groundwater Contamination Under Control [PDF 52.40 KB, 18 pp] has been verified.

Site Description

Novartis Pharmaceuticals Corporation is a 180-acre site, located at 59 Route 10, in an industrial, commercial and residential area of East Hanover, Morris County, New Jersey. The facility consists of a chemical manufacturing plant, a pharmaceutical packaging and compounding plant, and pharmaceutical research and development laboratories.
The company, which was formerly known as Sandoz, began operating in the mid-1950s.

The facility generates, stores and disposes of liquid and solid wastes during its manufacturing operations.  The wastes consist of organic and inorganic substances, including still bottom liquids, chlorinated solvents, caustic water solutions, waste oil and miscellaneous other solid and liquid wastes.  Hazardous wastes generated at the site are stored in one container storage area prior to being shipped off-site to an authorized facility.

Potential Threats and Contaminants

Groundwater is contaminated with chloroform, TCE, TCA, PCE and several inorganic constituents.  The main sources responsible for the organic contamination were leaking underground storage tanks, a wastewater lagoon, an inactive skimming tank, a former incinerator building and an inactive on-site treatment system.

Cleanup Approach and Progress

Novartis has characterized the hydrogeology of the site and the sources of contamination and it has been determined that the chloroform contamination in the sand and gravel aquifer is from an on-site source. Novartis also has removed all underground storage tanks and cleaned up contaminated soil.  All Solid Waste Management Units (SWMUs) and Areas Of Concern (AOCs) have been addressed and the remaining issues are vapor intrusion (VI) and site-wide groundwater.

Due to elevated chloroform concentrations in groundwater, Novartis submitted a remedial investigation workplan in which they will install additional groundwater monitoring wells to further define the chloroform plume. 

Concerning VI, Novartis needs to conduct additional investigation for 12 on-site buildings located in proximity to monitoring wells where groundwater levels were above NJDEP VI Guidance Screening Levels.   Novartis will address any necessary groundwater or VI mitigation issues based on the results of the additional investigation.

Site Repository

Copies of supporting technical documents and correspondence cited in the site fact sheet are available for public review at the following location:

New Jersey Department of Environmental Protection
Division of Solid & Hazardous Waste
Records Center
401 E. State Street, 6th Floor
Trenton, NJ 08625
Telephone (609) 777-3373
E-mail: records.custodian@dep.state.nj.us

The New Jersey Department of Environmental Protection (NJDEP) makes available its public records through formal request under the Open Public Records Act (OPRA).


Jump to main content.